CH586716A5 - - Google Patents

Info

Publication number
CH586716A5
CH586716A5 CH415576A CH415576A CH586716A5 CH 586716 A5 CH586716 A5 CH 586716A5 CH 415576 A CH415576 A CH 415576A CH 415576 A CH415576 A CH 415576A CH 586716 A5 CH586716 A5 CH 586716A5
Authority
CH
Switzerland
Application number
CH415576A
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/355,644 external-priority patent/US4094899A/en
Application filed by Pfizer filed Critical Pfizer
Publication of CH586716A5 publication Critical patent/CH586716A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH415576A 1972-06-02 1973-06-01 CH586716A5 (US06573293-20030603-C00184.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25921572A 1972-06-02 1972-06-02
US05/355,644 US4094899A (en) 1972-06-02 1973-04-30 Oxaprostaglandins

Publications (1)

Publication Number Publication Date
CH586716A5 true CH586716A5 (US06573293-20030603-C00184.png) 1977-04-15

Family

ID=26947161

Family Applications (3)

Application Number Title Priority Date Filing Date
CH797573A CH590224A5 (US06573293-20030603-C00184.png) 1972-06-02 1973-06-01
CH415576A CH586716A5 (US06573293-20030603-C00184.png) 1972-06-02 1973-06-01
CH415476A CH589074A5 (US06573293-20030603-C00184.png) 1972-06-02 1973-06-01

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH797573A CH590224A5 (US06573293-20030603-C00184.png) 1972-06-02 1973-06-01

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH415476A CH589074A5 (US06573293-20030603-C00184.png) 1972-06-02 1973-06-01

Country Status (19)

Country Link
JP (3) JPS5314062B2 (US06573293-20030603-C00184.png)
AR (2) AR199300A1 (US06573293-20030603-C00184.png)
CA (1) CA1095034A (US06573293-20030603-C00184.png)
CH (3) CH590224A5 (US06573293-20030603-C00184.png)
DD (2) DD109859A5 (US06573293-20030603-C00184.png)
DE (2) DE2344838C3 (US06573293-20030603-C00184.png)
DK (1) DK143498C (US06573293-20030603-C00184.png)
ES (2) ES441003A1 (US06573293-20030603-C00184.png)
FI (1) FI55995C (US06573293-20030603-C00184.png)
GB (3) GB1440603A (US06573293-20030603-C00184.png)
IE (1) IE38568B1 (US06573293-20030603-C00184.png)
IL (2) IL42373A (US06573293-20030603-C00184.png)
IN (1) IN138739B (US06573293-20030603-C00184.png)
LU (1) LU67738A1 (US06573293-20030603-C00184.png)
NL (1) NL162902C (US06573293-20030603-C00184.png)
NO (1) NO145438C (US06573293-20030603-C00184.png)
PH (3) PH11300A (US06573293-20030603-C00184.png)
SE (4) SE415756B (US06573293-20030603-C00184.png)
YU (1) YU36497B (US06573293-20030603-C00184.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES416865A1 (es) * 1972-07-13 1976-03-01 Pfizer Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15.
US11756356B2 (en) 2019-08-28 2023-09-12 Igloocompany Pte. Ltd. System and method for controlling multiple locks

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538120A (en) * 1967-05-22 1970-11-03 Ciba Geigy Corp Cyclopentyl-alkanoic acids
ZA721159B (en) * 1971-03-22 1972-12-27 Ici Ltd Process for the separation of the c-15 epimers of 20-ethyl-9a,11alpha,15-trihydroxy-5-cis-13-trans-prostadienoic acid

Also Published As

Publication number Publication date
IL50311A (en) 1977-08-31
CH589074A5 (US06573293-20030603-C00184.png) 1977-06-30
SE7608221L (sv) 1976-07-19
NO740849L (no) 1973-12-04
IE38568L (en) 1973-12-02
JPS5231054A (en) 1977-03-09
DD124594A5 (US06573293-20030603-C00184.png) 1977-03-02
FI55995B (fi) 1979-07-31
GB1440603A (en) 1976-06-23
JPS5314062B2 (US06573293-20030603-C00184.png) 1978-05-15
IL42373A (en) 1977-08-31
SE7608223L (sv) 1976-07-19
SE415756B (sv) 1980-10-27
PH11300A (en) 1977-11-02
DE2344838B2 (de) 1981-04-09
CH590224A5 (US06573293-20030603-C00184.png) 1977-07-29
AU5639373A (en) 1974-12-05
SE7608222L (sv) 1976-07-19
ES441002A1 (es) 1977-03-01
NO145438B (no) 1981-12-14
DE2344838A1 (de) 1973-12-20
ES441003A1 (es) 1977-03-16
DE2327813A1 (de) 1973-12-20
JPS4954349A (US06573293-20030603-C00184.png) 1974-05-27
NL162902C (nl) 1980-07-15
YU36497B (en) 1984-02-29
JPS5728706B2 (US06573293-20030603-C00184.png) 1982-06-18
DK143498B (da) 1981-08-31
DK143498C (da) 1982-01-11
NL7307740A (US06573293-20030603-C00184.png) 1973-12-04
NO145438C (no) 1982-03-24
IE38568B1 (en) 1978-04-12
DD109859A5 (US06573293-20030603-C00184.png) 1974-11-20
DE2344839B2 (de) 1976-06-24
GB1440602A (en) 1976-06-23
CA1095034A (en) 1981-02-03
GB1440601A (en) 1976-06-23
YU146973A (en) 1982-02-25
LU67738A1 (US06573293-20030603-C00184.png) 1973-12-10
NL162902B (nl) 1980-02-15
DE2344839A1 (de) 1974-02-28
SE418857B (sv) 1981-06-29
AR203386A1 (es) 1975-09-08
PH12035A (en) 1978-10-16
IN138739B (US06573293-20030603-C00184.png) 1976-03-27
DE2344838C3 (de) 1982-03-18
FI55995C (fi) 1979-11-12
IL42373A0 (en) 1973-07-30
JPS5239629A (en) 1977-03-28
AR199300A1 (es) 1974-08-23
PH11931A (en) 1978-09-13

Similar Documents

Publication Publication Date Title
JPS5330495B2 (US06573293-20030603-C00184.png)
JPS519220B2 (US06573293-20030603-C00184.png)
JPS5245911Y2 (US06573293-20030603-C00184.png)
JPS5728706B2 (US06573293-20030603-C00184.png)
JPS5241021B2 (US06573293-20030603-C00184.png)
JPS5224508Y2 (US06573293-20030603-C00184.png)
JPS5215139B2 (US06573293-20030603-C00184.png)
JPS548944B2 (US06573293-20030603-C00184.png)
JPS4913139A (US06573293-20030603-C00184.png)
CH315973A4 (US06573293-20030603-C00184.png)
CH570176A5 (US06573293-20030603-C00184.png)
BG18106A1 (US06573293-20030603-C00184.png)
CH575646A5 (US06573293-20030603-C00184.png)
BG18373A1 (US06573293-20030603-C00184.png)
BG18499A1 (US06573293-20030603-C00184.png)
BG22072A3 (US06573293-20030603-C00184.png)
CH574146A5 (US06573293-20030603-C00184.png)
CH573743A5 (US06573293-20030603-C00184.png)
CH575207A5 (US06573293-20030603-C00184.png)
CH575323A5 (US06573293-20030603-C00184.png)
CH572737A5 (US06573293-20030603-C00184.png)
CH1809873A4 (US06573293-20030603-C00184.png)
DD95306A1 (US06573293-20030603-C00184.png)
CH574911A5 (US06573293-20030603-C00184.png)
BG18059A1 (US06573293-20030603-C00184.png)

Legal Events

Date Code Title Description
PL Patent ceased